These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 38296625)
41. Distinct Recurrence Pattern and Survival Outcomes of Invasive Mucinous Adenocarcinoma of the Lung: The Potential Role of Local Therapy in Intrapulmonary Spread. Yoon DW; Hwang S; Hong TH; Choi YL; Kim HK; Choi YS; Kim J; Shim YM; Cho JH Ann Surg Oncol; 2024 Jan; 31(1):201-212. PubMed ID: 37814186 [TBL] [Abstract][Full Text] [Related]
42. Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer. He L; Huang Y; Chen X; Huang X; Wang H; Zhang Y; Liang C; Li Z; Yan L; Liu Z Front Immunol; 2022; 13():835630. PubMed ID: 35401554 [TBL] [Abstract][Full Text] [Related]
43. Surgical prognosis of lung invasive mucinous and non-mucinous adenocarcinoma: propensity score matched analysis. Lee JO; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Yun JK Eur J Cardiothorac Surg; 2024 Sep; 66(3):. PubMed ID: 39180480 [TBL] [Abstract][Full Text] [Related]
44. Radiological and clinical features of screening-detected pulmonary invasive mucinous adenocarcinoma. Kim DH; Bae SY; Na KJ; Park S; Park IK; Kang CH; Kim YT Interact Cardiovasc Thorac Surg; 2022 Jan; 34(2):229-235. PubMed ID: 34570199 [TBL] [Abstract][Full Text] [Related]
45. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy]. Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273 [No Abstract] [Full Text] [Related]
46. Value of the log odds of positive lymph nodes for prognostic assessment of colon mucinous adenocarcinoma: Analysis and external validation. Cai H; Xu T; Zhuang Z; Zhang Y; Gao Y; Liu X; Zhuang J; Yang Y; Guan G Cancer Med; 2021 Dec; 10(23):8542-8557. PubMed ID: 34796687 [TBL] [Abstract][Full Text] [Related]
47. The role of adenocarcinoma subtypes and immunohistochemistry in predicting lymph node metastasis in early invasive lung adenocarcinoma. Xue M; Liu J; Li Z; Lu M; Zhang H; Liu W; Tian H BMC Cancer; 2024 Jan; 24(1):139. PubMed ID: 38287300 [TBL] [Abstract][Full Text] [Related]
48. Prognostic Impact of Histopathologic Features in Pulmonary Invasive Mucinous Adenocarcinomas. Chang WC; Zhang YZ; Lim E; Nicholson AG Am J Clin Pathol; 2020 Jun; 154(1):88-102. PubMed ID: 32215558 [TBL] [Abstract][Full Text] [Related]
49. Proportion of goblet cell is associated with malignant potential in invasive mucinous adenocarcinoma of the lung. Oki T; Aokage K; Ueda T; Sugano M; Tane K; Miyoshi T; Kojima M; Fujii S; Kuwata T; Ochiai A; Funai K; Tsuboi M; Ishii G Pathol Int; 2019 Sep; 69(9):526-535. PubMed ID: 31559671 [TBL] [Abstract][Full Text] [Related]
50. Comparison of clinicopathological characteristics of mucinous adenocarcinoma and conventional adenocarcinoma of gallbladder. Zou RQ; Hu HJ; Liu F; Lv TR; Wang JK; Regmi P; Li FY Asian J Surg; 2023 Jan; 46(1):283-290. PubMed ID: 35422386 [TBL] [Abstract][Full Text] [Related]
51. The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database. Yu G; Liu X; Li Y; Zhang Y; Yan R; Zhu L; Wang Z Front Public Health; 2022; 10():946299. PubMed ID: 36159305 [TBL] [Abstract][Full Text] [Related]
52. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics. Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158 [TBL] [Abstract][Full Text] [Related]
53. The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features. Ma Z; Zhang Y; Deng C; Fu F; Deng L; Li Y; Chen H J Thorac Cardiovasc Surg; 2022 Jan; 163(1):e73-e85. PubMed ID: 32739163 [TBL] [Abstract][Full Text] [Related]
54. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma. Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204 [TBL] [Abstract][Full Text] [Related]
55. Optimal method for measuring invasive size that predicts survival in invasive mucinous adenocarcinoma of the lung. Oki T; Aokage K; Nomura S; Tane K; Miyoshi T; Shiiya N; Funai K; Tsuboi M; Ishii G J Cancer Res Clin Oncol; 2020 May; 146(5):1291-1298. PubMed ID: 32088782 [TBL] [Abstract][Full Text] [Related]
56. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [ Tsutani Y; Nakayama H; Ito H; Handa Y; Mimae T; Miyata Y; Okada M Clin Lung Cancer; 2021 May; 22(3):e431-e437. PubMed ID: 32665166 [TBL] [Abstract][Full Text] [Related]
57. Prognostic impact of mucin spread, tumor cell spread, and invasive size in invasive mucinous adenocarcinoma of the lung. Saito T; Tsuta K; Honda O; Ishida M; Yamaka R; Tanaka N; Ishida K; Utsumi T; Maru N; Matsui H; Taniguchi Y; Hino H; Kurata T; Murakawa T Lung Cancer; 2020 Aug; 146():50-57. PubMed ID: 32512273 [TBL] [Abstract][Full Text] [Related]
58. Genomic Profiling and Prognostic Value Analysis of Genetic Alterations in Chinese Resected Lung Cancer With Invasive Mucinous Adenocarcinoma. Cai L; Wang J; Yan J; Zeng J; Zhu L; Liang J; Pan C; Huang X; Jin J; Xu Y; Wang F; Shao Y; Xu Q; Xia G; Xing M; Xu X; Jiang Y Front Oncol; 2020; 10():603671. PubMed ID: 33505917 [TBL] [Abstract][Full Text] [Related]
59. Prognostic value of inferior mesenteric artery lymph node metastasis in cancer of the descending colon, sigmoid colon and rectum. Rao X; Zhang J; Liu T; Wu Y; Jiang Y; Wang P; Chen G; Pan Y; Wu T; Liu Y; Wan Y; Huang S; Wang X Colorectal Dis; 2018 Jun; 20(6):O135-O142. PubMed ID: 29577541 [TBL] [Abstract][Full Text] [Related]
60. Construction of the prognostic model for small-cell lung cancer based on inflammatory markers: A real-world study of 612 cases with eastern cooperative oncology group performance score 0-1. Liu C; Jin B; Liu Y; Juhua O; Bao B; Yang B; Liu X; Yu P; Luo Y; Wang S; Teng Z; Song N; Qu J; Zhao J; Chen Y; Qu X; Zhang L Cancer Med; 2023 Apr; 12(8):9527-9540. PubMed ID: 37015898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]